webinar register page

What does the Brexit effect mean for UK patient access? The implications of Brexit on European launch strategy

What does the Brexit effect mean for UK patient access?
Remap Consulting, joined by Paul Miller of NICE, will be reviewing the regulatory and market access impacts of Brexit on a manufacturer’s European launch sequence and will summarise the recent changes at NICE.

The panel will aim to answer these two questions:
• Will it be worth the trouble launching in the UK in five years’ time?
• Should the UK be deprioritised in the launch sequence?

Mar 29, 2022 09:00 PM in Amsterdam, Berlin, Rome, Stockholm, Vienna